Coronavirus Test Covid-19

Referencias

1. Romoli, M, Jelcic, I, Bernard-Valnet, R, García Azorín, D, Mancinelli, L, Akhvlediani, T et al.. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details. Eur. J. Neurol. 2020; :. doi: 10.1111/ene.14382. PubMed PMID:32503088 .
2. Lopes, RD, Macedo, AVS, de Barros E Silva, PGM, Moll-Bernardes, RJ, Feldman, A, D'Andréa Saba Arruda, G et al.. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial. Am. Heart J. 2020;226 :49-59. doi: 10.1016/j.ahj.2020.05.002. PubMed PMID:32502882 .
3. Ong, DSY, de Man, SJ, Lindeboom, FA, Koeleman, JGM. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected COVID-19 presenting to the hospital. Clin. Microbiol. Infect. 2020; :. doi: 10.1016/j.cmi.2020.05.028. PubMed PMID:32502646 .
4. Pormohammad, A, Ghorbani, S, Khatami, A, Farzi, R, Baradaran, B, Turner, DL et al.. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev. Med. Virol. 2020; :e2112. doi: 10.1002/rmv.2112. PubMed PMID:32502331 .
5. Yang, DM, Chang, TJ, Wang, ML, Tsai, PH, Lin, TH, Wang, CT et al.. Hunting severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research. J Chin Med Assoc. 2020;83 (6):524-526. doi: 10.1097/JCMA.0000000000000332. PubMed PMID:32502116 .